article
30 March 2021 | By Alp Tegin Sahin (Kadir Has University), Sheraz Gul (Fraunhofer Institute)
The length of time between the administration of a COVID-19 vaccine and evidence of a robust immune response to Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) means that treatments are still required. In this article, Sheraz Gul and Alp Tegin Sahin explore the various therapeutic targets that have been identified…